Objective: Understanding the role of T-cell immunoglobulin and mucin domaincontaining molecule 3 (Tim-3) on T cells and dendritic cells during the course of simian immunodeficiency virus (SIV) infection.
Introduction
During chronic viral infections with sustained antigen production, up to seven different inhibitory receptors have been associated with the down-modulation of T-cell responses, extending to a state of 'immune exhaustion' [1] . One such receptor is the T-cell immunoglobulin and mucin protein 3 (Tim-3), initially identified as a marker of T helper1 (Th1) but not Th2 cells [2] , and reasoned to be involved in the maintenance of peripheral tolerance and Treg function [3, 4] by interacting with Tim-3 ligands [3] . Previous studies suggested that Tim-3, similar to programmed death 1 (PD-1), might be an exhaustion marker with the progressive loss of cytokine production by Tim-3 þ T cells in tumors [5] [6] [7] .
T-cell immunoglobulin and mucin protein 3 expression has also been reported to increase during chronic viral infections on antigen-specific CD4 þ and CD8 þ T cells in mice and humans [8] [9] [10] [11] . In addition, Tim-3 expression has been associated with a state of T-cell exhaustion in terms of both cytokine production [9] and degranulating ability in cells from HIV and hepatitis C virus (HCV)infected patients [11] [12] [13] . However, there have been no reports on the expression and role of Tim-3 in nonhuman primate macaques in the context of simian immunodeficiency virus (SIV) infection until a recent report published during the redaction of the present article [14] , which provided the rationale for the studies reported herein. Results from our previous studies showed that blocking the PD-1/PDL pathway using soluble recombinant PD-1 protein led to the restoration of T-cell function, but resulted in limited clinical benefit [15] . The present study was initiated as a follow-up to investigate whether there might be a rationale for blocking both the Tim-3 and PD-1 pathway, simultaneously in the context of SIV infection to enhance antiviral responses.
Materials and methods
All animals used in this study were born at Yerkes National Primate Research Center and were maintained at the Yerkes National Primate Research Center of Emory University in accordance with the regulations of the Guide on the Care and Use of Laboratory Animal Resources. The experiments were approved by the Emory Institutional Animal Care and Use Committee as well as Biosafety Committee. The animals were inoculated with 200 TCID 50 (50% tissue culture infective dose) of SIVmac239 intravenously and served as a source for blood at various time points postinfection. Human blood was obtained from healthy donors after providing written informed consent, and the protocol was approved by the Institutional Review Board of Emory University.
Cryopreserved peripheral blood mononuclear cells (PBMCs) were stained for live/Dead marker (Alexa 430 Invitrogen A10169) and following antibodies against CD3 (SP34-2), CD4 (L200), CD8 (RPA-T8), CD20 (L27), CD28 (CD28.2), CD95 (DX2), PD1 (EH12.2H7), Tim-3 (344823, PE-conjugate, R&D or isotype control rat IgG2A-PE), Mamu-A Ã 001 APCtetramer (loaded with peptide CTPYDINQM) and Ki67 (B56), CD14 (M5E2), CD16 (3G8), HLA-DR (TU36), CD123 (7G3), CD11c (3.9), PD ligand 2 (PD-L2) (24F.10C12), and CD86 (IT2.2) were used. Stained cells were fixed in 1% paraformaldehyde (PFA), and acquired on a LSRII flow cytometer (BD Biosciences, Mountain View, California, USA). Analysis of the acquired data was performed using FlowJo software (version 9.2; TreeStar, Ashland, Oregon, USA). Statistical analyses were performed using GraphPad Insat version 3.00, and the graphs were generated in GraphPad Prism version 5.00. (GraphPad Software, San Diego, California, USA).
SIVgag-specific T-cell responses from freshly isolated PBMCs of infected monkeys were performed as previously described [15] .
Results
We evaluated the expression of Tim-3 on PBMCs from uninfected rhesus macaques and normal human donors. As shown in Fig. 1a , there are significant differences in the Tim-3 expression profile of PBMCs from healthy human donors and SIV-naïve rhesus macaques. The frequencies of Tim-3-expressing cells were markedly lower for CD4 þ (P ¼ 0.0043), CD8 þ T cells (P ¼ 0.0043), CD3 À / CD8a þ /NKG2A þ natural killer (NK) cells (P < 0.01), mDCs (P ¼ 0.02), and plasmacytoid dendritic cells (pDCs) (P ¼ 0.0007) from rhesus macaques compared to humans ( Fig. 1a ). In contrast, the frequencies of CD20 þ B cells from rhesus macaques that expressed Tim-3 were markedly higher than from humans (P ¼ 0.0043). The significant differences between these two species might suggest a potentially distinct role of Tim-3 in the context of a viral infection. We then investigated Tim-3 expression on PBMCs collected sequentially from rhesus macaques that were experimentally infected with SIVmac239. Four distinct subsets were identified for both CD8 þ and CD4 þ T cells (PD-1 þ Tim-3 À , PD1 þ Tim-3 þ , PD-1 À Tim-3 þ , and PD-1 À Tim-3 À ), but expression of Tim-3 was essentially restricted to PD1 þ T cells ( Fig. 1b ). Further characterization of PD1 þ Tim-3 þ T cells, using CD95 and CD28, indicated that these are primarily effector memory CD8 þ and central memory CD4 þ T-cell subsets (data not shown). The longitudinal data from baseline (week 8) to week 49 postinfection showed a clear but only transient upregulation of Tim-3 on both CD8 þ and CD4 þ T cells (week 2 to 6-8; Fig. 1c, d ). Of note, Tim-3 expression levels returned to baseline values by week 8 (CD8 þ T cells; Fig. 1c ) or week 12 (CD4 þ T cells; Fig. 1d ). There was also a significant increase in the mean fluorescence intensity (MFI) of Tim-3 on both CD4 þ and CD8 þ T cells at weeks 2 and 4, respectively, and though the frequencies dropped back to baseline values after week 8, the MFI remained higher than baseline levels (Supplementary Fig. S1 , http://links.lww.com/QAD/A639).
In contrast to the T cells, the frequencies of Tim-3 þ CD20 þ B cells did not vary significantly as a function of time after SIV infection ( Fig. 1e ). Tim-3 expression by NKG2A þ CD3 À cells before and after SIV infection showed a sustained increase as a function of time postinfection ( Fig. 1f ), confirming previous observations on human NK cells which showed that Tim-3 expression is up-regulated after activation [16] and that most mature NK cells (CD56 dim CD16 þ ) express Tim-3 [17] . Investigating p11CM tetramer þ CD8 þ T cells following the acute phase of infection showed high levels of PD-1 (as previously known), but only low levels of Tim-3 expression, which interestingly did not markedly vary over the 16-week follow-up period (Fig. 1g ). http://links.lww.com/QAD/A639). This strong association with early events of SIV infection supports Tim-3 as a marker of 'acute' T-cell activation.
A correlation analysis was performed between Tim-3expressing T-cell frequencies and acute events of SIV infection. Tim-3 expression on CD8
The CD14 þ CD16 À (classical), CD14 dim CD16 þþ (nonclassical) monocytes in PBMC did not show any detectable expression of Tim-3, irrespective of the SIV infection status (data not shown). This finding markedly differs from reports of Tim-3 expression by human monocytes [18] [19] [20] [21] . However, CD14 þ CD16 þ (Intermediate) monocytes showed modest Tim-3 expression with a mean value of 5.4 AE 6% SD at baseline and 3 AE 0.6% SD from week 1 to week 6 postinfection (data not shown). One-way analysis of variance (ANOVA) using the Tukey-Kramer multiple comparisons test showed that the variation of these frequencies was not statistically significant (data not shown).
PD-L1 (B7-H1) and PD-L2 (B7-DC) are well studied ligands for PD-1, and although they are structurally and genetically homologous, each has its unique functional properties [22] [23] [24] [25] . The expression of PD-L2 and Tim-3 was analyzed on dendritic cells in PBMC. Surprisingly, mDCs, defined as lineage (CD3, CD20, CD8, CD14, CD16) negative, but HLADR þ /CD123 À /CD11c þ , showed a clear separation between Tim-3 þ and PD-L2 þ mDCs (Fig. 1h, upper panel) . Monitoring Tim-3 and PD-L2 expression longitudinally showed a significant transient decrease in Tim-3 expressing mDCs at week 4 postinfection (P ¼ 0.02; Fig. 1i , solid line) followed by a restoration of Tim-3 þ mDCs by week 6, but overall lower levels during chronic infection (week 12 to 49 postinfection; P < 0.05). Interestingly, PD-L2expressing mDCs showed an opposite pattern to Tim-3 þ mDCs, which increased significantly after SIV infection and reached a peak at week 12 (P ¼ 0.002; Fig. 1i , broken line), suggesting a potential functional difference. There was a highly significant negative correlation between PD-L2 and Tim-3-expressing mDCs (Fig. 1j ). pDCs defined as lineage-negative, but HLADR þ /CD11c À /CD123 þ , also express Tim-3 ( Fig. 1h, lower panel) , but the levels were relatively low compared to mDCs. Increase in these frequencies was seen at week 2, but later samples were similar to baseline values before a new increase was noted at week 49 postinfection (Fig. 1k, solid line) .
PD-L2 expressing blood pDCs increased significantly after SIV infection peaked at week 8 (P ¼ 0.0002), but then drastically dropped to baseline levels at week 12 and remained low up to week 29, followed by modest increases in week 37 and beyond ( Fig. 1k, broken line) . However, unlike mDCs, the expression of Tim-3 and PD-L2 on pDCs showed no correlation (Fig. 1l ).
We also examined the antigen-specific responses in a 6-h intracellular cytokine secretion (ICS) assay with SIV gag peptides (2 mg/ml) using PBMCs collected at the acute (week 4 postinfection) and chronic (1 year postinfection) phase of infection. Total CD4 þ and CD8 þ T cells were divided into four different subsets based on PD-1 and Tim-3 expression. The responding cells among these four subpopulations were assessed for individual cytokine responses ( Fig. 2a, b ) and for polyfunctionality by using Boolean gates in FlowJo (Fig. 2c ). Values shown are net values adjusted by subtraction of responses obtained on an aliquot of the same cells without stimulation. As seen for both samples collected early and late postinfection, Tim-3 þ T cells were the major cytokine [interferon (IFN)-g, tumor necrosis factor (TNF)-a, interleukin (IL)-2, and CD107a] producing populations compared to other subsets regardless of whether they expressed PD-1 or not. Dual (d) and triple (t) cytokine producer T cells were predominantly Tim-3 þ (Fig. 2c ), suggesting that Tim-3 may be up-regulated primarily during antigenic stimulation. Similar data have been reported for effector CD4 þ and CD8 þ T cells from human patients with active tuberculosis (TB) infection [26] .
Discussion
The present study, to our knowledge, is the first analysis of the kinetics of Tim-3 expression on various cell lineages during SIV infection in rhesus macaques, though during submission of this manuscript, another study confirmed the low expression of TIM-3 on macaque T cells [14] . The transient up-regulation of Tim-3 levels on T cells during acute, but not chronic, SIV infection makes this finding difficult to reconcile, with the notion of Tim-3 being a marker of T-cell exhaustion in monkeys, as suggested by several studies on viral persistence and cancer [6, 7, 9, 11, 13, 27] . However, more profound was the finding of strong association with the early activation events during SIV infection, which strongly suggests its role as an 'acute' activation marker due to the rapid mobilization of the immune response to the nascent infection and not one of exhaustion. The low levels of Tim-3 on p11CM tetramer-specific cells compared to PD-1 shows that these two inhibitory receptors are differentially regulated. However, the fact that TIM-3 þ T cells are indeed antigen-specific effector cells even during chronic SIV infection further argues against an association of Tim-3 expression on macaque T cells and exhaustion -a fact that was corroborated in human CD4 þ and CD8 þ T cells from patients with active TB infection [26] , but contrasts a recent study of decreased antigen-specific IFN-g responses in T cells from SIV-infected macaques [14] . The reasons for this discrepancy are unclear at present, though this study used a polyclonal instead of the monoclonal anti-TIM-3 reagent used herein, and the antigen-specific cytokine analyses were restricted to IFN-g. Furthermore, the constitutive expression of Tim-3 on B cells and innate immune cells raises a note of caution regarding the use of Tim-3 blockade as a therapeutic strategy. Interestingly, rhesus macaques also showed high Tim-3-expressing mDCs as reported for humans [28] , and might have a similar role of secreting pro-inflammatory cytokines. The role of Tim-3 on dendritic cells as impeding antitumor function within the tumor microenvironment was shown in mice [29] , but its role in HIV/SIV still remains to be addressed. Our data also support a previous study [28] reporting opposing roles of Tim-3 in the adaptive and innate immune systems, as shown by the increase in Tim-3 þ T cells versus the decrease in Tim-3 þ mDCs after SIV infection. Acknowledgements P.K.A. was responsible for the concept and design of the study, performing experiments analyzing the data and writing the manuscript. J.J.H. contributed to the design of the study and data analysis. A.A.A. provided scientific input and assisted in manuscript revision. F.V. was responsible for the concept of the study and in revising the manuscript. We acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of (MHCI, p11CM) tetramer reagents, the Emory CFAR virology Core for the determination of plasma viral loads, the Resource for NHP immune reagents at Emory for the provision of recombinant cytokines and the NIH ARRRP for the provision of peptides.
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